Skip to main content
TipRanks
Go Ultimate75% OFF

Nishan Garabedian Christopher Insider Profile

4 Followers

Nishan Garabedian Christopher, President & CEO, Director at Sarepta Therapeutics, holds 29.55K shares in Sarepta Therapeutics (Ticker: SRPT).

Nishan Garabedian Christopher's Trading History

SRPT
Sarepta Therapeutics
Mar 03, 2015President & CEO, DirectorUninformative Buy9.45K$447.12K
SRPT
Insider Shares: 29.55K (0.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 03, 2015Uninformative Buy$9.45K800$11.81―
Apr 25, 2012Uninformative Buy$0.0081,666$0.00―
Dec 16, 2011Informative Buy$171.00K300,000$0.57+651.70%
Apr 06, 2011Informative Buy$195.00K130,000$1.50-36.00%

You May Also Like

Nishan Garabedian Christopher insider profile FAQ

What is the percentage of profitable transactions made by Nishan Garabedian Christopher?
The percentage of profitable transactions made by Nishan Garabedian Christopher is 50%.
What is the average return per transaction made by Nishan Garabedian Christopher?
The average return per transaction made by Nishan Garabedian Christopher is 307.80%.
What stocks does Nishan Garabedian Christopher hold?
Nishan Garabedian Christopher holds: SRPT stocks.
What was Nishan Garabedian Christopher’s latest transaction?
Nishan Garabedian Christopher’s latest transaction was an Uninformative Buy of $9.45K.
What was Nishan Garabedian Christopher's most profitable transaction?
Nishan Garabedian Christopher’s most profitable transaction was an Informative Buy of SRPT stock on December 16, 2011. The return on the trade was 651.70%.
What is Nishan Garabedian Christopher's role in Sarepta Therapeutics?
Nishan Garabedian Christopher's role in Sarepta Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.